A combination of the cholesterol/cholate treatment with a HF diet induced human NASH-like morphology (including MDBs and ballooned hepatocytes) with an even faster occurrence (after 12 weeks instead of 24 weeks) and without increased insulin sensitivity [173,174]. Here, INS is linked to metabolic dysfunction-associated steatohepatitis.